Clinical trials
Phase 1 Colitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 4 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Altheus Therapeutics, Inc. | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Bristol-Myers Squibb | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| McMaster Children's Hospital | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Odense University Hospital | 1 |
| Rise Therapeutics LLC | 1 |
| University Hospital, Bordeaux | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis | 12 |
| Colitis, Ulcerative | 4 |
| Inflammatory Bowel Diseases | 4 |
| Lung Neoplasms | 2 |
| Ulcer | 2 |
| Urogenital Neoplasms | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Cholangitis, Sclerosing | 1 |
Trials
Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.